Abstract
In the UK no medicine can be marketed for human use without a Product Licence granted by the Licensing Authority (Ministers of Health).1 Licensing arrangements, which are determined by the Medicines Act 1968 and implemented through the Medicines Control Agency (MCA), constrain drug companies but leave doctors free to prescribe unlicensed drugs or use drugs for unlicensed indications. This article discusses how the licensing status affects prescribing.
Subject
Pharmacology (medical),General Medicine
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献